Conneqt Health Ltd logo

Conneqt Health Ltd (CQTHF)

Market Closed
7 Aug, 20:00
OTC PINK OTC PINK
$
0. 40
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 0.4
Previous Close
Add Transaction
Day Range
0.4 0.4
Year Range
0.4 0.4
Want to track CQTHF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CQTHF closed Friday higher at $0.4, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, CQTHF stock gained 0%.
CQTHF is not paying dividends to its shareholders.
The last earnings report, released on Mar 04, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Conneqt Health Ltd has completed 1 stock splits, with the recent split occurring on Feb 18, 2022.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on ASX (AUD).

CQTHF Chart

Conneqt Health Ltd (CQTHF) FAQ

What is the stock price today?

The current price is $0.40.

On which exchange is it traded?

Conneqt Health Ltd is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is CQTHF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Conneqt Health Ltd ever had a stock split?

Conneqt Health Ltd had 1 splits and the recent split was on Feb 18, 2022.

Conneqt Health Ltd Profile

- Industry
- Sector
Mr. Craig R. Cooper BEC, L.L.B. CEO
OTC PINK Exchange
AU0000420739 ISIN
Australia Country
- Employees
- Last Dividend
17 Feb 2022 Last Split
- IPO Date

Overview

CONNEQT Health Limited is an innovative health technology company that excels in the design, manufacture, and marketing of advanced medical devices with a concentrated emphasis on cardiovascular health management. The company’s flagship technology is rooted in the patented SphygmoCor vascular biometric platform, which allows for noninvasive measurement of central hemodynamics and arterial stiffness. This technology equips healthcare providers and patients with clinically validated vascular biomarkers, including central aortic pressures. Targeting various markets, CONNEQT offers products suitable for consumers as well as hospitals, clinics, research institutions, and pharmaceutical companies on a global scale, particularly in the Americas, Europe, and Asia Pacific.

By integrating medical devices with digital solutions and wearables, CONNEQT Health is transforming how healthcare is delivered. The company emphasizes home health monitoring, decentralized clinical trials, and remote patient care, thereby positioning itself at the forefront of the expanding longevity and preventive cardiovascular health market. With a comprehensive approach that provides clinical-grade insights for both consumers and health professionals, CONNEQT addresses critical aspects of early detection and management of hypertension, cardiovascular disease, and associated vascular disorders.

Products and Services

  • CONNEQT Pulse
    A consumer-targeted, FDA-cleared arterial health monitor designed to help individuals track and manage their cardiovascular health. The device provides users with valuable insights into their arterial health through accessible and easy-to-understand metrics.
  • SphygmoCor XCEL
    Aimed at hospitals, clinics, and research institutions, SphygmoCor XCEL is an advanced vascular health monitoring system that offers valuable insights into central hemodynamics and arterial stiffness. It is a clinically validated solution preferred by healthcare professionals for comprehensive cardiovascular assessment.
  • Wearable Health Devices
    CONNEQT Health integrates wearables that seamlessly connect with its medical devices, enhancing home health monitoring capabilities, enabling real-time data collection, and fostering better patient engagement and adherence to health regimens.
  • Digital Health Solutions
    The company offers a suite of digital solutions designed to support remote patient care and decentralized clinical trials. These solutions leverage data analytics to provide actionable insights and facilitate better clinical decision-making.
  • Clinical Trials and Research Support
    By collaborating with pharmaceutical companies and research institutions, CONNEQT Health provides essential tools and insights necessary for conducting decentralized clinical trials, emphasizing patient safety and data integrity.

Contact Information

Address: 55 Lime Street
Phone: 61 2 9874 8761